Phoenix Holdings Ltd. Red Hill Biopharma Ltd. Transaction History

Phoenix Holdings Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$2.31 - $5.85 $38,295 - $96,981	-16,578 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$4.55 - $10.36 $75,429 - $171,748	16,578 New	16,578 $75,000
Q2 2021 Aug 10, 2021	SELL	$5.98 - $7.51 $136,302 - $171,175	-22,793 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$6.98 - $11.29 $561,073 - $907,524	-80,383 Reduced 77.91%	22,793 $163,000
Q4 2020 Feb 11, 2021	SELL	$7.81 - $10.39 $51,897 - $69,041	-6,645 Reduced 6.05%	103,176 $880,000
Q3 2020 Nov 10, 2020	BUY	$6.34 - $10.83 $64,230 - $109,718	10,131 Added 10.16%	109,821 $1.06 Million
Q2 2020 Aug 10, 2020	BUY	$4.6 - $8.6 $61,718 - $115,386	13,417 Added 15.55%	99,690 $640,000
Q1 2020 May 20, 2020	BUY	$3.51 - $6.17 $302,818 - $532,304	86,273 New	86,273 $379,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.